Effects of Percutaneous Coronary Interventions in Silent Ischemia After Myocardial Infarction: The SWISSI II Randomized Controlled Trial
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
CONTEXT: The effect of a percutaneous coronary intervention (PCI) on the long-term prognosis of patients with silent ischemia after a myocardial infarction (MI) is not known. OBJECTIVE: To determine whether PCI compared with drug therapy improves long-term outcome of asymptomatic patients with silent ischemia after an MI. DESIGN, SETTING, AND PARTICIPANTS: Randomized, unblinded, controlled trial (Swiss Interventional Study on Silent Ischemia Type II [SWISSI II]) conducted from May 2, 1991, to February 25, 1997, at 3 public hospitals in Switzerland of 201 patients with a recent MI, silent myocardial ischemia verified by stress imaging, and 1- or 2-vessel coronary artery disease. Follow-up ended on May 23, 2006. INTERVENTIONS: Percutaneous coronary intervention aimed at full revascularization (n = 96) or intensive anti-ischemic drug therapy (n = 105). All patients received 100 mg/d of aspirin and a statin. MAIN OUTCOME MEASURES: Survival free of major adverse cardiac events defined as cardiac death, nonfatal MI, and/or symptom-driven revascularization. Secondary measures included exercise-induced ischemia and resting left ventricular ejection fraction during follow-up. RESULTS: During a mean (SD) follow-up of 10.2 (2.6) years, 27 major adverse cardiac events occurred in the PCI group and 67 events occurred in the anti-ischemic drug therapy group (adjusted hazard ratio, 0.33; 95% confidence interval, 0.20-0.55; P<.001), which corresponds to an absolute event reduction of 6.3% per year (95% confidence interval, 3.7%-8.9%; P<.001). Patients in the PCI group had lower rates of ischemia (11.6% vs 28.9% in patients in the drug therapy group at final follow-up; P = .03) despite fewer drugs. Left ventricular ejection fraction remained preserved in PCI patients (mean [SD] of 53.9% [9.9%] at baseline to 55.6% [8.1%] at final follow-up) and decreased significantly (P<.001) in drug therapy patients (mean [SD] of 59.7% [11.8%] at baseline to 48.8% [7.9%] at final follow-up). CONCLUSION: Among patients with recent MI, silent myocardial ischemia verified by stress imaging, and 1- or 2-vessel coronary artery disease, PCI compared with anti-ischemic drug therapy reduced the long-term risk of major cardiac events. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00387231.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Optimal Medical Therapy with or without PCI for Stable Coronary Disease
Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070829 · Cited by 4,699 · cited 2×
“Thus, these findings reflect the standard of clinical practice in patients with significant post-MI silent ischemia, patients who are different from most who were enrolled in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.(23) Recently, the Open Artery Trial (OAT) repo…”
BackgroundCoronary Intervention for Persistent Occlusion after Myocardial Infarction
Hochman, J. S., Lamas, G. A., Buller, C. E., Dzavik, V., Reynolds, H. R., Abramsky, S. J., Forman, S., Ruzyllo, W., Maggioni, A. P., White, H., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066139 · Cited by 732
Self-citationDavies, R. F., Goldberg, A. D., Forman, S., Pepine, C. J., Knatterud, G. L., Geller, N., Sopko, G., Pratt, C., Deanfield, J., & Conti, C. R. (1997) · Circulation · doi:10.1161/01.cir.95.8.2037 · Cited by 461
Pepine, C. J., Cohn, P. F., Deedwania, P. C., Gibson, R. S., Handberg, E., Hill, J. A., Miller, E., Marks, R. G., & Thadani, U. (1994) · Circulation · doi:10.1161/01.cir.90.2.762 · Cited by 339
Cohn, P. F., Fox, K. M., of, W. T. A., & Daly, C. (2003) · Circulation · doi:10.1161/01.cir.0000088001.59265.ee · Cited by 329
Prognostic significance of silent myocardial ischemia in patients with unstable angina
Nademanee, K., Intarachot, V., Josephson, M. A., Rieders, D., Mody, F. V., & Singh, B. N. (1987) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(87)80152-3 · Cited by 295
Prognostic significance of ischemic episodes in patients with previous myocardial infarction
Tzivoni, D., Gavish, A., Zin, D., Gottlieb, S., Moriel, M., Keren, A., Banai, S., & Stern, S. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)91198-8 · Cited by 243
Dargie, H. J., Ford, I., Fox, K. M., & on behalf of the TIBET study group (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014668 · Cited by 229
Dakik, H. A., Kleiman, N. S., Farmer, J. A., He, Z.-X., Wendt, J. A., Pratt, C. M., Verani, M. S., & Mahmarian, J. J. (1998) · Circulation · doi:10.1161/01.cir.98.19.2017 · Cited by 126
Knatterud, G. L., Bourassa, M. G., Pepine, C. J., Geller, N. L., Sopko, G. S., CHAITMAN, B. R., Pratt, C., Stone, P. H., Davies, R. F., Rogers, W. J., et al. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90535-5 · Cited by 119
Zellweger, M. J., Weinbacher, M., Zutter, A. W., Jeger, R. V., Mueller‐Brand, J., Kaiser, C. A., Buser, P. T., & Pfisterer, M. E. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00557-6 · Cited by 110
Self-citationPepine, C. J., Geller, N. L., Knatterud, G. L., Bourassa, M. G., Chaitman, B. R., Davies, R. F., Day, P., Deanfield, J. E., Goldberg, A. D., McMahon, R. P., et al. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90534-7 · Cited by 105
von Arnim, T. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00122-2 · Cited by 77
Pfisterer, M. E., Rickenbacher, P. R., Kiowski, W., Müller‐Brand, J., & Burkart, F. E. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90556-g · Cited by 54
Self-citationKayden, D. S., Wackers, F. J. T., & Zaret, B. L. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)92817-l · Cited by 47
Long-term follow-up of patients with silent ischemia during exercise radionuclide angiography
Breitenbücher, A., Pfisterer, M. E., Hoffmann, A., & BURCKHARDT, D. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90231-d · Cited by 35
Self-citationForslund, L., Hjemdahl, P., Held, C., Eriksson, S. V., Björkander, I., & Rehnqvist, N. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00526-3 · Cited by 24
Conti, C. R. (2002) · Current Opinion in Cardiology · doi:10.1097/00001573-200209000-00015 · Cited by 17
Cited by
2018 ESC/EACTS guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167
WRITING COMMITTEE MEMBERS*, O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182742cf6 · Cited by 4,725
2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510
Self-citation(2014) · European Heart Journal · doi:10.1093/eurheartj/ehu278 · Cited by 4,314
Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention
Tonino, P. A. L., De Bruyne, B., Pijls, N. H. J., Siebert, U., Ikeno, F., van `t Veer, M., Klauss, V., Manoharan, G., Engstrøm, T., Oldroyd, K. G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807611 · Cited by 4,260
Metadata
- Authors
- Erne, P., Schoenenberger, A. W., Burckhardt, D., Zuber, M., Kiowski, W., Buser, P. T., Dubach, P., Resink, T. J., & Pfisterer, M.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2007-05-09
- Volume
- 297
- Issue
- 18
- Pages
- 1985
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2098258573
- Cited by
- 311
- References
- 20
- FWCI
- 27.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.